Myriam Curet Sells 230 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 230 shares of the business’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $532.61, for a total value of $122,500.30. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Myriam Curet also recently made the following trade(s):

• On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The shares were sold at an average price of $559.90, for a total value of $58,229.60.
• On Monday, November 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The stock was sold at an average price of $560.00, for a total value of $58,800.00.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $3.00 during trading hours on Wednesday, reaching $522.04. 1,850,622 shares of the company’s stock traded hands, compared to its average volume of 2,102,794. The firm has a market capitalization of $187.14 billion, a price-to-earnings ratio of 66.16, a PEG ratio of 4.12 and a beta of 1.67. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08. The firm’s 50 day moving average is $561.53 and its 200-day moving average is $511.67.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the firm posted $2.21 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ISRG. Raymond James Financial lifted their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. UBS Group restated a “neutral” rating on shares of Intuitive Surgical in a report on Thursday, January 15th. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Argus increased their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Finally, Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $620.41.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. Tobam increased its position in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the last quarter. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. raised its stake in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares during the period. Kilter Group LLC bought a new position in Intuitive Surgical during the second quarter worth $27,000. Finally, Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical in the third quarter valued at $27,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA cleared the da Vinci 5 for select advanced cardiac procedures, expanding Intuitive’s addressable market in minimally invasive heart surgery — a potential medium‑term revenue catalyst. ISRG’s da Vinci Gets FDA Nod for Advanced Cardiac Procedures
• Positive Sentiment: TD Cowen initiated/upgraded coverage to a strong‑buy / buy stance, providing a fresh bullish analyst view that can support investor confidence. TD Cowen initiates coverage of Intuitive Surgical (ISRG) with buy recommendation
• Positive Sentiment: HSBC published a bullish forecast calling for strong price appreciation, and Barclays reiterated a buy — additional institutional analyst support that may offset short‑term weakness. HSBC Forecasts Strong Price Appreciation for Intuitive Surgical Barclays Remains a Buy on Intuitive Surgical (ISRG)
• Positive Sentiment: Polen Capital highlighted ISRG as a position for future growth in its Q4 letter, indicating continued institutional interest from growth managers. Polen Capital Bets on Robotic Surgery Leader Intuitive Surgical (ISRG)
• Neutral Sentiment: Market commentary questioned whether it’s time to reassess ISRG after recent share‑price weakness — useful context for momentum traders but not a direct company action. Is It Time To Reassess Intuitive Surgical (ISRG) After Recent Share Price Weakness?
• Negative Sentiment: Director Gary S. Guthart sold a large block of shares (reported filings show major sales on Jan. 27 totaling millions of dollars), which can be interpreted negatively by the market as signaling reduced insider conviction or tax/liquidity actions. SEC Filing — Gary S. Guthart
• Negative Sentiment: EVP Myriam Curet disclosed a smaller sale (230 shares), adding to the day’s insider sell narrative although impact is small relative to Guthart’s trades. SEC Filing — Myriam Curet

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.